EUVIMEDOpdag EUVIMED
FallberichtOpen access · CC BY 4.0

First reported human Castellaniella defragrans bacteraemia: a case report

Morgane Nédellec, Titouan Cerruti, Damien Jacot iD, Gilbert Greub iD, Malik Benmachiche iD

Swiss Medical Weekly · 2026

DOI: 10.57187/5401 ↗

At a glance

Fallbericht in Swiss Medical Weekly, 2026. Written by Morgane Nédellec and 4 co-authors. Institution: Division of Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland. Major MEDLINE topics: Bacteremia, Gram-Negative Bacterial Infections, Leukemia, Lymphocytic, Chronic, B-Cell. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Castellaniella defragrans is an environmental Gram-negative, non-fermenting β-proteobacterium that is not known as a human pathogen. Here, we report the first documented case of C. defragrans bacteraemia in an 82-year-old man with monoclonal B-cell lymphocytosis, subsequently diagnosed with chronic lymphocytic leukaemia, who presented with fever, confusion and clinical signs of sepsis. Blood cultures showed sustained growth of C. defragrans for 7 days. Imaging revealed pulmonary consolidations and mediastinal infiltration suggestive of mediastinitis. Further investigations did not identify a clear additional infectious focus. In addition, an immunological evaluation revealed severe cellular and humoral immunosuppression. Antimicrobial therapy with high-dose meropenem led to bacteraemia clearance and progressive clinical improvement. Treatment was completed with oral sulfamethoxazole–trimethoprim for a total of five weeks. This case highlights the potential of environmental microorganisms to cause severe infections in immunocompromised hosts.

Subjects

MeSH terms (MEDLINE)

BacteremiaGram-Negative Bacterial InfectionsLeukemia, Lymphocytic, Chronic, B-CellHumansAged, 80 and overMaleAnti-Bacterial AgentsImmunocompromised HostMeropenemTrimethoprim, Sulfamethoxazole Drug CombinationThienamycins

Substances

Anti-Bacterial AgentsMeropenemTrimethoprim, Sulfamethoxazole Drug CombinationThienamycins

Authors and institutions

  • Division of Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland.
  • Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Division of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland.

ORCID profiles: Damien Jacot, Gilbert Greub, Malik Benmachiche

Cite

APA

Nédellec, M., Cerruti, T., Jacot, D., Greub, G., & Benmachiche, M. (2026). First reported human Castellaniella defragrans bacteraemia: a case report. Swiss Medical Weekly. https://doi.org/10.57187/5401

Vancouver

Nédellec M, Cerruti T, Jacot D, Greub G, Benmachiche M. First reported human Castellaniella defragrans bacteraemia: a case report. Swiss Medical Weekly. 2026. doi:10.57187/5401

BibTeX
@article{Ndellec2026,
  author = {Nédellec, Morgane and Cerruti, Titouan and Jacot, Damien and Greub, Gilbert and Benmachiche, Malik},
  title = {First reported human Castellaniella defragrans bacteraemia: a case report},
  journal = {Swiss Medical Weekly},
  year = {2026},
  doi = {10.57187/5401}
}
Start for free →